Biological Information
Background Information:
Imidazoline receptors constitute a family of (non-adrenergic) receptors that represent a heterogenous family of membrane proteins. The imidazoline I2 receptor subclass is considered to be mitochondrial, not G protein coupled, and shown to be present in brain and peripheral tissues. Imidazoline I2 receptor agonism may enhance narcotic analgesia and contribute to centrally mediated hypotension.
Family:
Transmembrane (Other)
Sub Family:
Imidazoline
Organism:
Rat
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Brains (except cerebella) of male Wistar derived rats weighing 175 ± 25 g are used to prepare imidazoline I2 receptors in modified Tris-HCl buffer pH 7.4. A 15 mg‡ aliquot is incubated with 2 nM [³H] Idazoxan for 30 minutes at 25℃. Non-specific binding is estimated in the presence of 1 μM idazoxan. Membranes are filtered and washed, the filters are then counted to determine [³H] Idazoxan specifically bound. Compounds are screened at 10 μM.
Note: ‡ Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.
Ligand:
[³H] Idazoxan
Ligand Kd (nM):
4
Ligand Concentration:
2 nM
Non Specific:
1 µM Idazoxan
Incubation:
30 min at 25°C
Control Inhibitor:
Idazoxan
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Cardiovascular
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS